Immune Checkpoint Blockade (ICB) has reshaped cancer care and can deliver durable remission in malignancies such as melanoma and non-small cell lung cancer.
LUND, SE / ACCESS Newswire / January 23, 2026 / Cantargia AB (Publ) (STO:CANTA) today reported that the first patient has been dosed in a Phase 1b/2 clinical trial investigating nadunolimab in combina ...
Defendant at Longford District Court disqualified for eight years and directed to complete 240 hours of community service ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback